Company news

Biotron Limited news in 2022

Biotron Limited's news releases, calls and decks from 2022, newest first.

View company

$1.43M R&D rebate received

November 18, 2022

Commencement of Rights Trading - BITRC

October 31, 2022

Renounceable Issue

October 26, 2022

Second BIT225 Phase 2 HIV-1 Clinical Trial Fully Recruited

October 3, 2022

Bit225 Covid-19 Human Study Commenced

September 13, 2022

BIT225 Phase 2 HIV-1 Clinical Trial Fully Recruited

August 23, 2022

Positive FDA guidance for covid-19 clinical program

May 30, 2022

BIT225 effective against established sars-cov-2 in animals

May 2, 2022

Quarterly Cash Flow Report Appendix 4C

April 26, 2022

Quarterly Activities Report

April 26, 2022

$1.56M R&D Rebate Received

April 5, 2022

BIT225 Effectiveness Against COVID-19 in Animals

March 17, 2022

Quarterly Appendix 4C Cash Flow Report

January 27, 2022

Decks in 2022